Northwest Biotherapeutics completes direct public offering

Northwest Biotherapeutics Inc. (NASDAQ:NWBO), Bethesda, Md. Business: Cancer Date completed: 2016-02-29 Type: Direct public offering Raised: $10 million Shares: 5.9 million Price: $1.70 Shares after o...